All Posts Tagged With: "BDSI"
(CEPH) Cephalon Second Quarter 2010 Earnings Report Beats The Street
Cephalon Inc. (CEPH) delivered another strong quarter with second quarter earnings coming in at $2.05 per share, six cents above the Zacks Consensus Estimate and well above the year-ago earnings of $1.44...
(CEPH) Cephalon’s Quarterly Earnings Report Beats – Updates Guidance
Cephalon, Inc. (CEPH) started 2010 on a strong note with first quarter earnings beating expectations by a wide margin. The company reported first quarter earnings of $1.76 per share, 20 cents above the Zacks...
(CEPH) Cephalon Earnings Estimates Up on Company Guidance
Earnings estimates for Cephalon, Inc. (CEPH) have gone up significantly following the issuance of a better-than-expected guidance by the company. Cephalon exited 2009 on a strong note with both fourth-quarter...
(CEPH) Cephalon Beats Earnings Expectations and Guides Higher
Cephalon, Inc. (CEPH) exited 2009 on a strong note with both fourth quarter and full year earnings exceeding expectations. The company reported fourth quarter earnings of $1.66 per share, 6 cents above the...
(CEPH) Cephalon Settles Barr Pharmaceuticals Challenge
Earlier this month, Cephalon Inc. (CEPH) announced that it has settled its patent infringement case with Barr Pharmaceuticals,...
($CEPH) Cephalon Beats Forecasts – Provides Outlook
Cephalon Inc. (CEPH) reported strong third-quarter earnings of $1.62 per share that easily surpassed the Zacks Consensus Estimate of $1.42 per share and the year ago earnings of $1.18. Revenues increased...